Address
The Bank of Tokyo - Mitsubishi UFJ Capital Co Ltd
2-7-1 Marunouchi
Chiyoda-ku
Tokyo
104-0031
Japan
Phone
Industry
Business classification
VCID: 3408
Profile
Corporate information
Official name
The Bank of Tokyo - Mitsubishi UFJ Capital Co Ltd
Registration country
Official name
The Bank of Tokyo - Mitsubishi UFJ Capital Co Ltd
Registration country
Investment activity status
Active investor
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Skybox Security Inc Enterprise security software company. |
United States | 28 Dec 2009 | Series D Initial investment. Round participant. Active |
|
|
Teknovus Inc EPON chipsets company that support IPTV-triple-play services via optical fiber networks. |
United States | 16 Nov 2009 | N/A Initial investment. Round participant. Active |
|
|
Cambrios Technologies Corp Developer of proprietary nanostructured electronic materials for the display industry |
United States | 1 Nov 2009 | Series D Initial investment. Round participant. Active |
|
|
NeoPhotonics Corp Developer and vertically integrated manufacturer of photonic integrated circuit based components, modules and subsystems for use in telecommunications |
United States | 19 Jun 2006 | Series C Initial investment. Round participant. Active |
|
|
|
Cswitch Inc Developer of next-generation configurable devices. |
United States | 30 May 2006 | Series B Initial investment. Round participant. Active |
|
|
|
Raven Biotechnologies Inc A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. |
United States | 12 Oct 2005 | Series D Initial investment. Round participant. Active |
|
|
|
Inotek Pharmaceuticals Corp Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Five Prime Therapeutics Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Cardiac Dimensions Inc Medical device company developing novel interventional tools for the treatment of heart failure & the related condition of mitral valve regurgitation. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Acologix Inc Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Dynogen Pharmaceuticals Inc Drug company focused on gastrointestinal and genitourinary disorders. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
AVEO Pharmaceuticals Inc Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. |
United States | N/A Initial investment. Round participant. Active |